Skip to main content

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Joaquin Ruiz Altarejo

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Ramon Gonzalez Rioja

Ramon Gonzalez Rioja

Predoctoral researcher
Pharmacokinetic Nanoparticles
Read more
Maria Molinos Marquez

Maria Molinos Marquez

Tècnic/a de Laboratori
High Technology Unit (UAT)
Preclinical Core Facilities
External Strategy Directorate
Read more
Lluria Cornellas Escayola

Lluria Cornellas Escayola

Read more
Sara Lopez Gonzalez

Sara Lopez Gonzalez

Research technician
Rheumatology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.